» Articles » PMID: 38695027

Impact of the Gut Microbiome on Skin Fibrosis: a Mendelian Randomization Study

Overview
Specialty General Medicine
Date 2024 May 2
PMID 38695027
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Skin fibrosis is a lesion in the dermis causing to itching, pain, and psychological stress. The gut microbiome plays as an essential role in skin diseases developments. We conducted a Mendelian randomization study to determine the causal association between the gut microbiome and skin fibrosis.

Methods: We retrieved valid instrumental variables from the genome-wide association study (GWAS) files of the gut microbiome ( = 18,340) conducted by the MiBioGen consortium. Skin fibrosis-associated data were downloaded from the GWAS Catalog. Subsequently, a two-sample Mendelian randomization (MR) analysis was performed to determine whether the gut microbiome was related to skin fibrosis. A reverse MR analysis was also performed on the bacterial traits which were causally associated with skin fibrosis in the forward MR analysis. In addition, we performed an MR-Pleiotropy Residual Sum and Outlier analysis to remove outliers and a sensitivity analysis to verify our results.

Results: According to the inverse variance-weighted estimation, we identified that ten bacterial traits (, , , , , , , and ) were negatively correlated with skin fibrosis while five bacterial traits (, , , ), and ) were positively correlated. No results were obtained from reverse MR analysis. No significant heterogeneity or horizontal pleiotropy was observed in MR analysis.

Objective Conclusion: There is a causal association between the gut microbiome and skin fibrosis, indicating the existence of a gut-skin axis. This provides a new breakthrough point for mechanistic and clinical studies of skin fibrosis.

Citing Articles

The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential.

Jimenez-Sanchez M, Celiberto L, Yang H, Sham H, Vallance B Gut Microbes. 2025; 17(1):2473524.

PMID: 40050613 PMC: 11901370. DOI: 10.1080/19490976.2025.2473524.


Skin Microbiota, Immune Cell, and Skin Fibrosis: A Comprehensive Mendelian Randomization Study.

Zhao Z, Rong Y, Yin R, Zeng R, Xu Z, Lv D Biomedicines. 2024; 12(10).

PMID: 39457721 PMC: 11505207. DOI: 10.3390/biomedicines12102409.

References
1.
Zhao Y, Zhang B, Liu C, Ren G . Method for accurate diagnose of lupus erythematosus skin lesions based on microbial rDNA sequencing. Saudi J Biol Sci. 2020; 27(8):2111-2115. PMC: 7376186. DOI: 10.1016/j.sjbs.2020.05.035. View

2.
Griffin M, Huber J, Evan F, Quarto N, Longaker M . The role of Wnt signaling in skin fibrosis. Med Res Rev. 2021; 42(1):615-628. DOI: 10.1002/med.21853. View

3.
Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano G, Gasbarrini A . What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019; 7(1). PMC: 6351938. DOI: 10.3390/microorganisms7010014. View

4.
Sorboni S, Moghaddam H, Jafarzadeh-Esfehani R, Soleimanpour S . A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders. Clin Microbiol Rev. 2022; 35(1):e0033820. PMC: 8729913. DOI: 10.1128/CMR.00338-20. View

5.
van der Velde K, Imhann F, Charbon B, Pang C, van Enckevort D, Slofstra M . MOLGENIS research: advanced bioinformatics data software for non-bioinformaticians. Bioinformatics. 2018; 35(6):1076-1078. PMC: 6419911. DOI: 10.1093/bioinformatics/bty742. View